Sergei Gryaznov
Vermögen: 64 650 $ am 31.05.2026
Vermögen: 64 650 $ am 31.05.2026
Sergei M.
Gryaznov is the founder of Lynx Therapeutics, Inc. (1993).
Current job includes Chief Scientific Officer at MAIA Biotechnology, Inc. (2019 - present).
Former jobs include Chemistry Director at Geron Corp.
(2013) and Chief Technology Officer at Exicure Operating Co. Education includes graduate and doctorate degrees from Moscow State University Lomonosov.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MAIA BIOTECHNOLOGY, INC. 0,08 % | 01.06.2026 | 46.511 ( 0,08 % ) | 64 650 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MAIA BIOTECHNOLOGY, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
| GERON CORPORATION | Corporate Officer/Principal | 01.01.2013 |
Lynx Therapeutics, Inc.
Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Corporate Officer/Principal | 01.01.1997 |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Lynx Therapeutics, Inc.
Lynx Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops genetic analysis products for the pharmaceutical, biotechnology and agriculture industries | Health Technology |
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Moscow State University Lomonosov
Moscow State University Lomonosov Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Health Technology |
MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops cancer therapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen